Oruka Therapeutics, Inc. ORKA Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s net income?
- Oruka Therapeutics, Inc. (ORKA) reported net income of -$31.82M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s net income changed year-over-year?
- Oruka Therapeutics, Inc.'s net income decreased by 51.5% year-over-year, from -$21M to -$31.82M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s net income?
- Over 4 years (2021 to 2025), Oruka Therapeutics, Inc.'s net income has grown at a 52.8% compound annual growth rate (CAGR), from -$19.32M to -$105.43M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.